NEW YORK (GenomeWeb News) – Bio-Rad Laboratories has agreed to purchase Ciphergen’s proteomics instrument business for approximately $20 million in cash, Ciphergen said yesterday. Bio-Rad is also making a $3 million equity investment in Ciphergen.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.